» Articles » PMID: 33282675

Occurrence, Fate and Removal of SARS-CoV-2 in Wastewater: Current Knowledge and Future Perspectives

Overview
Publisher Elsevier
Date 2020 Dec 7
PMID 33282675
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The coronavirus disease 2019 (COVID-19), a pandemic of global concern, is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recently, many studies have documented the detection of SARS-CoV-2 in human excreta and wastewater. The presence of SARS-CoV-2 in human excreta and wastewater poses serious implications for wastewater treatment. Thus, this review aims to understand the fate of SARS-CoV-2 in the urban water cycle and its inactivation in different stages of treatment in wastewater treatment plants (WWTPs) for effective control to prevent any recurrence of the outbreak. The viral load of SARS-CoV-2 in feces of individuals tested positive has been reported to be in the range of 10-10 copies/L depending on the infection stages. In the wastewater, dilution of feces results in the decrease of the viral load in the range of 10-10 copies/L. Monitoring of SARS-CoV-2 in WWTP samples following the wastewater-based epidemiology (WBE) can complement real epidemiological data from clinical testing to help to monitor disease outbreaks in a community. Though promising, high uncertainty involved with the WBE technique warrants further research for reliable and quantitative information. Inactivation of SARS-CoV-2 in WWTPs depends on the operational parameters and is generally enhanced by the tertiary treatment and disinfection techniques with a higher dosage. However, the risk of SARS-CoV-2 dissemination by the treated effluent intended to be disposed of or reused in the urban water cycle needs to be assessed with respect to the extent of viral infectivity.

Citing Articles

A panoramic view of the virosphere in three wastewater treatment plants by integrating viral-like particle-concentrated and traditional non-concentrated metagenomic approaches.

Zhang J, Tang A, Jin T, Sun D, Guo F, Lei H Imeta. 2024; 3(3):e188.

PMID: 38898980 PMC: 11183165. DOI: 10.1002/imt2.188.


An interpretative review of the wastewater-based surveillance of the SARS-CoV-2: where do we stand on its presence and concern?.

Gogoi G, Singh S, Kalyan E, Koch D, Gogoi P, Kshattry S Front Microbiol. 2024; 15:1338100.

PMID: 38318336 PMC: 10839012. DOI: 10.3389/fmicb.2024.1338100.


Monitoring Prevalence and Persistence of Environmental Contamination by SARS-CoV-2 RNA in a Makeshift Hospital for Asymptomatic and Very Mild COVID-19 Patients.

Yang J, Sun D, Xia T, Shi S, Suo J, Kuang H Int J Public Health. 2023; 68:1605994.

PMID: 37767017 PMC: 10520216. DOI: 10.3389/ijph.2023.1605994.


Importance of wastewater-based epidemiology for detecting and monitoring SARS-CoV-2.

Sridhar J, Parit R, Boopalakrishnan G, Rexliene M, Praveen R, Viswananathan B Case Stud Chem Environ Eng. 2023; 6:100241.

PMID: 37520919 PMC: 9341170. DOI: 10.1016/j.cscee.2022.100241.


Occurrence and transport of SARS-CoV-2 in wastewater streams and its detection and remediation by chemical-biological methods.

Bhattacharya S, Abhishek K, Samiksha S, Sharma P J Hazard Mater Adv. 2023; 9:100221.

PMID: 36818681 PMC: 9762044. DOI: 10.1016/j.hazadv.2022.100221.


References
1.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

2.
Wang X, Li J, Jin M, Zhen B, Kong Q, Song N . Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J Virol Methods. 2005; 126(1-2):171-7. PMC: 7112909. DOI: 10.1016/j.jviromet.2005.02.005. View

3.
Hung L . The SARS epidemic in Hong Kong: what lessons have we learned?. J R Soc Med. 2003; 96(8):374-8. PMC: 539564. DOI: 10.1177/014107680309600803. View

4.
Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X . Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020; 5(5):434-435. PMC: 7158584. DOI: 10.1016/S2468-1253(20)30083-2. View

5.
Xu D, Zhang Z, Jin L, Chu F, Mao Y, Wang H . Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur J Clin Microbiol Infect Dis. 2005; 24(3):165-71. PMC: 7088045. DOI: 10.1007/s10096-005-1299-5. View